A New Jersey law allowing terminally ill individuals to request life-ending substances has been upheld by a federal appeals court, which clarified that the law applies exclusively to state residents. This ruling by the 3rd U.S. Circuit Court of Appeals rejects challenges to the law’s residency requirement, acknowledging the intricate nature of end-of-life choices in the broader context of varying state laws.
U.S. Circuit Judge Stephanos Bibas articulated in his opinion, Death brings good things to an end, but rarely neatly. Many terminally ill patients face a grim reality: imminent, painful death. Some may wish to avert that suffering by seeking medical assistance in ending their lives. New Jersey allows its residents to make that choice—but only its residents.
The ruling follows legislation enacted in 2019, which includes specifics such as requiring two doctors’ approvals and mandates that patients must be adults who can express their wishes voluntarily. A key aspect of the law is that patients must submit written requests for the medication, with provisions for them to rescind their decision.
This legal ruling emerged from a distressing case where a Delaware woman with stage 4 lymphoma sought the option of doctor-assisted suicide but sadly passed away prior to the court's decision. Starting January 1, Delaware will implement its own assisted suicide law.
As of now, New Jersey, along with the District of Columbia and ten other states, authorizes assisted suicide for terminally ill patients, although typically limited to residents of those states, with only Oregon and Vermont offering this option to non-residents.
The New Jersey law mandates that at least one of the two required witnesses to the written requests must not be related to the patient or be a healthcare provider involved in their care. The precise legality surrounding assisted suicide continues to evolve across states, emphasizing the significant variance in how end-of-life rights are approached.
